GLP-1 medications can be a powerful tool for those who are on a weight loss journey
Ozempic, a GLP-1 receptor agonist, and metformin, an oral biguanide, are considered first-line treatments for Type 2 diabetes, with their choice influenced by patient-specific factors
Semaglutide itself has minimal direct blood pressure-lowering effects, but weight loss achieved through treatment typically reduces blood pressure by 515 mmHg over 812 weeks
Some patients explore peptide therapy as part of broader wellness and body composition goals that may include exercise, nutrition, and healthy lifestyle modifications
In addition, four different classes of this superfamily, called beta (), delta(), phi () and tau () are also present in bacteria, insects and plants